You are here: Industry Insights > NMPA

News List

Weekly Pharma News Review | PharmaSources.com (March 14 to 18) PharmaSources/Caicai
March 25, 2022
One of the most exciting news of this week was the marketing approval of duvelisib capsules, a dual PI3K inhibitor introduced by CSPC Pharmaceutical Group Co., Ltd.
Weekly Pharma News Review | PharmaSources.com (March 7 to 12) PharmaSources.com
March 16, 2022
The news review of this week is from March 7 to 12, covering a total of 20 pieces of information in 4 sections, i.e. review, R&D, business, and listing.
Weekly Pharmaceutical News Review | PharmaSources.com (Feb. 28th to March.4th) PharmaSources.com
March 16, 2022
The most talked-about news of this week is the successful overseas marketing of Nanjing LEGN.US's CAR-T, which not only demonstrates the strength of China's innovative biologics but also eases the anxiety of Chinese innovative drug companies.
Fighting Against COVID-19: Summary of Key Products PharmaSources/Recollect
February 22, 2022
Since the outbreak of COVID-19 in 2019, many kinds of COVID-19 vaccines, COVID-19 preventive drugs and COVID-19 therapeutic drugs have been approved worldwide.
With the help of Multiple Parties, the Pediatric Drugs Market Space has been Expanding PharmaSources/Yi
November 08, 2021
Recently, cyclophosphamide capsules of Hengrui Medicine and human growth hormone recombination injection of GeneScience Pharmaceuticals were proposed to be included in the priority review by CDE...
Analysis and Policy Review of Pediatric Drug Market of China PharmaSources/Zhulikou431
May 31, 2021
As mentioned in the previous article, the U.S. is currently the largest pediatric drug market in the world, followed by China.
This Japanese Enterprise Refused the Inspection of the Chinese Drug Regulator PharmaSources/Laoxue
September 23, 2020
The Japanese pharmaceutical enterprise: Sanyo Chemical Laboratories Co., Ltd.’s refusal of the NMPA’s inspection was disclosed and exposed by the NMPA on July 31.
Pharmaceutical News of the Week (July. 13th-July. 17th) | PharmaSources.com - Updates on Approvals PharmaSources/Caicai
July 22, 2020
With the third week of July coming to a close, let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions, and miscellany that happened during July 13-17, including 30 pieces.
Pharmaceutical News of the Week (June. 29th-July. 3rd) | PharmaSources.com - Updates on Policies PharmaSources/Caicai
July 08, 2020
Let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions and listing that happened during June 29-July 3, including 29 pieces.
Second ADC Therapeutic Drug Was Approved for Marketing in China CPhI.CN
May 14, 2020
Takeda Pharmaceutical's application of vebutuximab for injection has been approved and became the second ADC drug approved in the Chinese market.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page